Derma-Med SRL
Derma-Med reported total assets of 134,562 € at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Jul 2026).
The score of Derma-Med shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -30 % Total assets -27 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Derma-Med's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 22,443 € | ||||
| Equity | 63,602 € | ||||
| Cash | 30,566 € | ||||
| EBITDA | 57,227 € | ||||
| Total assets | 134,562 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jul 2026
- Year ended 31 Dec 2024filed on 17 Jul 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 01 Oct 2023
- Year ended 31 Dec 2021filed on 05 Aug 2022
Derma-Med's financial analysis
- Solvency47.3%sector median: 67.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Derma-Med
Derma-Med's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0832.863.378
- VAT number
- BE0832863378
- Peppol
- Registered · 0208:0832863378 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Jan 2011
- Registered office
- 1150 Woluwe-Saint-Pierre
- Latest accounts
- 2025 · filed on 03 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
Derma-Med (SRL) has been based in Woluwe-Saint-Pierre since 2011, active in: medical specialists activities. For 2025, it reports a net profit of 22,443 € and equity of 63,602 €; its revenue is not published. Its solvency stands at 47.3%, below the median of its sector (67.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Derma-Med
Companies in the same business, of comparable size and area, outside its group.
- AnesTHeezy Medical specialists activities Wezembeek-Oppem · balance sheet 156,828 €
- Medic Esthetic Brussels Beauty care and other beauty treatment activities Uccle · balance sheet 90,256 €
- DR Tazeroualti Beauty care and other beauty treatment activities Ixelles · balance sheet 307,048 €
- Docteur Emilie GODINAS Medical specialists activities Esneux · balance sheet 193,848 €
- Société médicale docteurs Dormal Lebas Medical specialists activities Esneux · balance sheet 673,434 €
- Radiant Skin Medical specialists activities Namur · balance sheet 129,249 €
- DR Arthur Basso ORL Medical specialists activities Liège · balance sheet 143,351 €
- Dr. Peeters Valérie - Dermatologie Medical specialists activities Diepenbeek · balance sheet 149,828 €
Frequently asked questions about Derma-Med
What is the revenue of Derma-Med?
Derma-Med files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Derma-Med?
In Belgium, the VAT number is the company number prefixed with BE: BE0832863378 for Derma-Med, if the company is VAT-registered. Its company number (CBE) is 0832.863.378.
Where is the registered office of Derma-Med?
According to the CBE register, the registered office of Derma-Med is in 1150 Woluwe-Saint-Pierre.
What is the equity of Derma-Med?
At the close of the 2025 financial year, the equity of Derma-Med amounts to 63,602 €, a solvency of 47.3% of total assets.
Who manages Derma-Med?
The register lists 1 active mandates at Derma-Med. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Derma-Med
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →